Abstract
This article presents experience from the practice of a successful pharmaceutical company related to design and implementation of performance measures (PMs) for deviation management linked to the analysis of impact on the production cost for the selected product. Case study focuses on PMs within good manufacturing practice (GMP) processes related to quality assurance (QA) and quality management, with the aim of complying with its future requirements proposed by the European Commission. Critical areas were identified based on data gathered from the industrial deviation database. Implementation of the suggested corrective actions showed significant improvement in terms of reducing their number for more than 50% per selected deviation category. The results obtained in the course of this practice-oriented study contribute to further improvement of deviation management in the pharmaceutical industry and performance measurement of other GMP processes. The suggested performance measurement concept and problem-solving techniques may serve both practitioners and the decision-makers within QA and quality control (QC) in order to improve their processes by implementing relevant regulatory requirements for quality management and maintain compliance.
References
Geijo F (2000) Quality management in analytical R&D in the pharmaceutical industry: building quality from GLP. Accred Qual Assur 5:16–20
Kovac G, Porubenova A (2008) Evaluation of the quality of clinical laboratories in the Slovak, Republic: conceptual and contextual remarks. Accred Qual Assur 13:165–171
Krouwer JS (2006) Dynamic rather than static performance measures are needed to improve patient safety. Accred Qual Assur 11:644–646
Pohl B, Simon S, Kramer P-J (2008) Current experiences with a quality management system for non-clinical research and development in pharmaceutical industry. Accred Qual Assur 13:511–521
Fabregas-Fernandez A, Garcia-Montoya E, Perez-Lozano P, Sune-Negre JM, Tico JR, Minarro M (2009) Quality assurance in research: incorporating ISO 9001:2000 into a GMP quality management system in a pharmaceutical R+D+I center. Accred Qual Assur. Published online: 10 Nov 2009
Schmidt P (1999) Integrating accreditation, good laboratory practice and good manufacturing practice in an industrial analytical laboratory. Accred Qual Assur 4:129–132
Bonk-Kassner C, Ehmann J, Gallhoff G, Moore DS, Moos B, Siegemund B (1997) Integration of parallel-operating quality systems. Accred Qual Assur 2:285–293
Ehrmeyer SS, Laessig RH (2008) Can auditing save us from a quality disaster? Accred Qual Assur 13:139–144
GMP Part I (2008) Basic requirements for medicinal products
Saeed Arayne M, Najma S, Kamran Zaman M (2008) Historical incidents leading to the evolution of good manufacturing practice. Accred Qual Assur 13:431–432
ISO 9001:(2008) Quality management systems—requirements
EU Guidelines to Good Manufacturing Practice Medicinal Products for Human and Veterinary Use Part I—Draft (2009) http://ec.europa.eu/enterprise/newsroom/cf/document.cfm?action=display&doc_id=5587&userservice_id=1. Accessed 16 Feb 2010
Parmenter D (2007) Key performance indicators (KPI): developing, implementing and using winning KPIs. Wiley, London
Nunnally BK, McConnell JS (2007) Six sigma in the pharmaceutical industry. CRC Press, Cleveland
McGurk TL, Snee RD (2005) A systematic approach to deviation reduction through six Sigma. Pharm Technol Sourc Manag 7:4–18
Neely A, Richards H, Mills J, Platts K, Bourne M (1997) Designing performance measures: a structured approach. Int J Oper Prod Manag 17:1131–1152
Acknowledgments
The authors are grateful to Hemofarm, Serbia and the Ministry of Science and Technological Development of the Republic of Serbia for the support (project TR 21006 and 34009).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Boltic, Z., Ruzic, N., Jovanovic, M. et al. Measuring the performance of quality assurance processes: pharmaceutical industry deviation management case study. Accred Qual Assur 15, 629–636 (2010). https://doi.org/10.1007/s00769-010-0709-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00769-010-0709-2